Studies on the chemopreventive potentials of vegetable oils and unsaturated fatty acids against breast cancer carcinogenesis at initiation

European Journal of Cancer Prevention

Volumn 13, Issue 4, 2004, Pages 239-248

  Yu, F L ^a   Greenlaw, R ^a   Fang, Q ^a   Bender, W ^a   Yamaguchi, K ^a   Xue, B H ^a   Yu, C C ^a  

^a UNIVERSITY OF ILLINOIS AT URBANA CHAMPAIGN   (United States)

Author keywords

17 Estradiol; 17 estradiol epoxide; Breast cancer prevention; DNA adducts; RNA synthesis; Unsaturated fatty acids; Vegetable oils

Indexed keywords

ARACHIDONIC ACID; CARCINOGEN; DIMETHYLDIOXIRANE; DNA; EPOXIDE; ESTRADIOL; LINOLEIC ACID; LINOLENIC ACID; MONOUNSATURATED FATTY ACID; NUCLEAR RNA; NUCLEOTIDE; OLEIC ACID; PALMITOLEIC ACID; PHOSPHORUS 32; POLYUNSATURATED FATTY ACID; TRITIUM; VEGETABLE OIL;

ARTICLE; BREAST CANCER; CANCER PREVENTION; CARCINOGENESIS; CHEMICAL BOND; CHEMOPROPHYLAXIS; DIET; DNA ADDUCT; DNA BINDING; EPOXIDATION; FATTY ACID ANALYSIS; PRIORITY JOURNAL; RNA SYNTHESIS; RNA TRANSLATION;

ANIMALS; ANTICARCINOGENIC AGENTS; BREAST NEOPLASMS; CHEMOPREVENTION; DIETARY FATS; DNA ADDUCTS; DNA, RIBOSOMAL; ESTRADIOL; FATTY ACIDS, UNSATURATED; FEMALE; HUMANS; PLANT OILS; RATS; RNA, MESSENGER; SENSITIVITY AND SPECIFICITY; TUMOR CELLS, CULTURED;

EID: 4143141202     PISSN: 09598278     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.cej.0000137375.84544.ee     Document Type: Article

References (44)

1. Adam W, Chan YY, Cremer D, et al. (1987). Spectral and chemical properties of dimethyldioxirane as determined by experiment and ab initio calculations. J Org Chem 52: 2800-2803.
2. Bergkvist L, Adami HO, Personn I, et al. (1989). The risk of breast cancer after estrogen and estrogen-progestin replacement. N Engl J Med 321: 293-297.
3. Colditz GA (1998). Relationship between estrogen levels, use of hormone replacement therapy, and breast cancer. J Natl Cancer Inst 90: 814-823.
4. Dipple A (1995). DNA adducts of chemical carcinogens. Carcinogenesis 16: 437-441.
5. Farber E (1984). Cellular biochemistry of the stepwise development of cancer with chemicals: G H A Clowes memorial lecture. Cancer Res 44: 5463-5474.
6. Greenwald P (1999). Role of dietary fat in the causation of breast cancer: point. Cancer Epidemiol Biomarkers Prev 8: 3-7.
7. Hankinson SE, Willett WC, Manson JE, et al. (1998). Plasma sex steroid hormone levels and risk of breast cancer in postmenopausal women. J Natl Cancer Inst 90: 1292-1299.
8. Hemminki K (1993). DNA adducts, mutations and cancer. Carcinogenesis 14: 2007-2012.
9. Holmes MD, Hunter DJ, Colditz GA, et al. (1999). Association of dietary intake of fat and fatty acids with risk of breast cancer. JAMA 281: 914-920.
10. Hunter DJ (1999). Role of dietary fat in the causation of breast cancer: counterpoint. Cancer Epidemiol Biomarkers Prev 8: 9-13.
11. 1: mechanistic studies. J Am Chem Soc 116: 1603-1609.
12. Miller EC, Miller JA (1981). Searches for ultimate chemical carcinogens and their reactions with cellular macromolecule. Cancer 47: 2327-2345.
13. Park KK, Sohn Y, Liem A, et al. (1997). The electrophilic and tumorigenic activities of phenyl and 4-nitrophenyl vinyl ethers and their epoxide metabolites. Carcinogenesis 18: 431-437.
14. Randerath K, Randerath E, Agrawal HP (1984). Biochemical (postlabeling) Methods for Analysis of Carcinogen-DNA Adducts. IARC Scientific Publication No. 59. Lyon: IARC; pp. 217-231.
15. 32P]-post-labeling test for structurally diverse DNA adducts. Carcinogenesis 7: 1543-1551.
16. 32P-analysis of DNA adducts in somatic and productive tissues of rats treated with anticancer antibiotic, mitomycin C. Mutation Res 179: 75-88.
17. Richter WO (2003). Fatty acids and breast cancer - is there a relationship? Eur J Med Res 8: 373-380.
18. Ross RK, Paganini-Hall A, Wan P, et al. (2000). Effect of hormone replacement therapy on breast cancer: estrogen versus estrogen plus progestin. J Natl Cancer Inst 92: 328-332.
19. Rossouw JE, Anderson GL, LaCroix AZ, et al. (2002). Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results from the women's health initiative randomized controlled trial. JAMA 288: 321-333.
20. Schairer C, Lubin J, Troisi R, et al. (2000). Menopausal estrogen and estrogen-progestin replacement therapy and breast cancer. JAMA 283: 485-491.
21. Smith-Warner SA, Speigelman D, Adami HO (2001). Types of dietary fat and breast cancer: a pooled analysis of cohort studies. Int J Cancer 92: 767-774.
22. Toniolo PG, Levitz M, Zeleniuch-Jacquotte A, et al. (1995). A prospective study of endogenous estrogens and breast cancer in postmenopausal women. J Natl Cancer Inst 87: 190-197.
23. Trichopoulou A, Katsouyanni K, Struver S, et al. (1995). Consumption of olive oil and specific food groups in relation to breast cancer risk in Greece. J Natl Cancer Inst 87: 110-116.
24. Velie E, Kulldorff M, Schairer C, et al. (2000). Dietary fat, fat subtypes, and breast cancer in postmenopausal women: a prospective cohort study. J Natl Cancer Inst 92: 833-839.
25. Weisburger EK (1980). Metabolism and activation of chemical carcinogens. Mol Cell Biochem 32: 95-104.
26. Wolk A, Bergstrom R, Hunter D, et al. (1998). A prospective study of association of monounsaturateo fat and other types of fat with risk of breast cancer. Arch Intern Med 158: 41-45.
27. Wynder EL, Cohen LA, Muscat JE, et al. (1997). Breast cancer: weighing the evidence for a promoting role of dietary fat. J Natl Cancer Inst 89: 766-775.
28. Yu FL (1974). An improved method for the quantitative isolation of rat liver nuclear RNA polymerases. Biochim Biophys Acta 395: 329-336.
29. 1 inhibition of rat hepatic nuclear RNA synthesis. J Biol Chem 252: 3245-3251.
30. Yu FL (2002). 17β-estradiol epoxidation as the molecular basis for breast cancer initiation and prevention. Asian Pacific J Clin Nutr 11 (Suppl 7): S460-S466.
31. Yu FL, Bender W (1995). Studies on the isolated transcriptionally active and inactive chromatin fractions from rat liver nuclei. J Biochem Biophys Methods 30: 21-36.
32. Yu FL, Bender W (1996). Activation of 17β-estradiol and estrone by dimethyldioxirane and inhibition of rat liver nuclear and nucleolar RNA synthesis in vitro. Carcinogenesis 17: 1957-1961.
33. Yu FL, Bender W (2002). A proposed mechanism of tamoxifen in breast cancer prevention. Cancer Detect Prev 26: 370-375.
34. 1-8,9-epoxide. Carcinogenesis 15: 1737-1741.
35. 1-8,9-epoxide-DNA adducts on transcription of a supF gene fragment. Cancer Lett 109: 77-83.
36. Yu FL, Wang MY, Li DH, et al. (1998a). Evidence for the DNA binding and adduct formation of estrone and 17β-estradiol after dimethyldioxirane activation. Chem Biol Interactions 110: 173-187.
37. Yu FL, Bender W, Zheng WY, et al. (1998b). The transcriptional effects and DNA-binding specificities of 17β-estradiol after dimethyldioxirane activation. Carcinogenesis 19: 1127-1131.
38. Yu FL, Wang MY, Bender W (1998c). A hypothesis on breast cancer. In: Ioannidou-Mouzaka L, Agnantis NJ, Lopez DM (editors): 22nd Congress of the International Association for Breast Cancer Research, 24-28 September, Athens, Greece. Bologna: Monduzzi Editore; pp. 19-24.
39. Yu FL, Zheng WY, Wang MY, et al. (1999a). The effect of 17β-estradiol-DNA adducts on the replication of exon no. 5 of the human tumor suppressor gene p53. FEBS Lett 454: 7-10.
40. Yu FL, Wang MY, Bender W (1999b). Evidence for an initiation mechanism of 17β-estradiol carcinogenesis. Proc Am Assoc Cancer Res 40: 45 (abstract 302).
41. Yu FL, Wang MY, Bender W (2001a). Evidence for an initiation mechanism of 17β-estradiol carcinogenesis. In: Li JJ, Daling J, Li SA (editors): Hormonal Carcinogenesis III. New York: Springer-Verlag; pp. 444-450.
42. Yu FL, Riordan B, Yu CC, et al. (2001b). Screen vegetable oils for chemopreventive potentials. Proc Am Assoc Cancer Res 42: 869 (abstract 4663).
43. Yu FL, Greenlaw R, Englert H, et al. (2002). Studies on unsaturated fatty acids for chemopreventive potentials. Proc Am Assoc Cancer Res 43: 825 (abstract 4096).
44. Yu FL, Bender W, Fang Q, et al. (2003). Prevention of chemical carcinogen DNA binding and inhibit of nuclear RNA polymerase activity by organosulfur compounds as the possible mechanisms for their anticancer initiation and proliferative effects. Cancer Detect Prev 27: 370-379.